ADMA Biologics, Inc.ADMANASDAQ
LOADING
|||
Price to Sales: Premium Valuation
Trending higher, above historical average.
Left:
||||
Price-to-sales ratio
Latest
9.37
↑ 58% above average
Average (9y)
5.92
Historical baseline
Range
High:11.71
Low:2.43
CAGR
-2.4%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 9.37 | +139.1% |
| 2023 | 3.92 | -21.3% |
| 2022 | 4.98 | +104.9% |
| 2021 | 2.43 | -38.9% |
| 2020 | 3.98 | -46.3% |
| 2019 | 7.41 | +16.5% |
| 2018 | 6.36 | +96.9% |
| 2017 | 3.23 | -44.7% |
| 2016 | 5.84 | -50.1% |
| 2015 | 11.71 | - |